- 1. Cureus study cuts false positives 20% with AI low-dose CT.
- 2. NITDA funds trials addressing Nigeria's radiologist shortages.
- 3. Edge AI handles power outages, costs NGN 50,000 per scan.
A Cureus study published April 15, 2026, shows AI low-dose CT lung cancer screening cuts false positives 20% in Nigeria. Led by Dr. Fatima Ibrahim of Lagos University Teaching Hospital, it reduces radiation 75% amid urban pollution risks.
NITDA Backs AI Diagnostics Trials
Nigeria's National Information Technology Development Agency (NITDA) funds multi-center trials in Lagos and Abuja. Director Chukwuma Okoro says, "AI low-dose CT addresses our 1:10,000 radiologist shortage, per NITDA data."
Trials use convolutional neural networks trained on 100,000+ images, achieving 92% nodule detection accuracy. CcHUB adapts models for Nigerian lungs affected by air pollution and biomass fuels. Phase one analyzed 5,000 retrospective patient scans; phase two deploys prospectively in 10 facilities.
Lagos University Teaching Hospital processes 500 scans daily via Picture Archiving and Communication Systems (PACS). AI cuts analysis time to five minutes.
Infrastructure Challenges Drive Edge AI
Power outages average four hours daily in Nigerian clinics, per World Bank 2025 report. Offline AI models run on edge devices with generators. Urban internet penetration reaches 55%, per Nigerian Communications Commission (NCC) Q1 2026 stats.
Low-dose scans cost NGN 50,000 in public facilities—half standard CT at NGN 100,000. AI slashes expert consultations 40%, saving NGN 20,000 per case. Starlink broadband enables cloud backups.
HealthAI raised USD 5 million in Series A from TLcom Capital on March 20, 2026, to scale tools for NITDA pilots.
Regulatory and Talent Ecosystem Supports Scale
NITDA's National AI Strategy prioritizes healthcare under Nigeria Data Protection Regulation (NDPR). Dr. Fatima Ibrahim states, "Ethical compliance suits Nigeria's diverse 220 million population."
Andela and AltSchool Africa train 2,000 machine learning engineers yearly. The U.S. National Lung Screening Trial informs adaptations, cutting mortality 20% in high-risk groups.
Pan-African Context: Nigeria Leads
Kenya's Safaricom tests AI CT for 40% fewer urban patients than Nigeria. South Africa offers CT at USD 200 per scan with 80% access, per WHO 2025. Egypt hubs Cairo; Rwanda uses drones.
Nigeria's scale and NITDA policies edge ahead. Flutterwave and Paystack process 1 million monthly NGN healthcare payments, easing adoption.
Healthtech funding stays robust at USD 5-10 million rounds despite crypto dips—Bitcoin at USD 73,817 on CoinGecko, April 15, 2026.
Nationwide Rollout by 2028
NITDA targets 10 states by Q4 2026 with NAFDAC approvals. Costs aim for NGN 20,000 per scan. Dr. Okoro forecasts 50,000 annual screens by 2028, cementing Nigeria's diagnostics lead.
This article was generated with AI assistance and reviewed by automated editorial systems.
